Shares of Great Basin Scientific (GBSN) Drops by -8.46%

Great Basin Scientific (GBSN) : During the past 4 weeks, traders have been relatively bearish on Great Basin Scientific (GBSN), hence the stock is down -38.7% when compared to the S&P 500 during the same period. However, in the past 1 week, the selling of the stock is down by -9.81% relative to the S&P 500. The 4-week change in the price of the stock is -36.02% and the stock has fallen -8.46% in the past 1 week. The stock has recorded a 20-day Moving Average of 26.99% and the 50-Day Moving Average is 38.94%.

Great Basin Scientific (NASDAQ:GBSN): The stock opened at $1.33 on Friday but the bulls could not build on the opening and the stock topped out at $1.34 for the day. The stock traded down to $1.05 during the day, due to lack of any buying support eventually closed down at $1.19 with a loss of -17.93% for the day. The stock had closed at $1.45 on the previous day. The total traded volume was 3,056,856 shares.


The company Insiders own 1.7% of Great Basin Scientific shares according to the proxy statements. Institutional Investors own 1.06% of Great Basin Scientific shares. In a related news, The Securities and Exchange Commission has divulged in a Form 4 filing that the director of Great Basin Scientific, Inc., Spafford David had purchased shares worth of $9,798 in a transaction dated on August 21, 2015. A total of 6,665 shares were purchased at a price of $1.47 per share. The information is based on open market trades at the market prices.Option exercises are not covered.

Great Basin Scientific, Inc. is a molecular diagnostic testing company. The Company is focused on the development and commercialization of its molecular diagnostic platform designed to test for infectious disease. The Company has a commercially available test, a diagnostic test for clostridium difficile (C. diff), which received clearance from the Food and Drug Administration (FDA). The Companys products under development also include a diagnostic test for Group B Strep., Staphylococcus Identification and Resistance Blood Infection Panel (Staph ID/R panel), STEC Test, Staph aureus (SA) Pre-Surgical Nasal Screen Test, Food Borne Pathogens Panel and Candida Blood Infection Panel. The Companys platform is an automated molecular diagnostic system, consisting of an analyzer and associated diagnostic tests.

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *

Get Pre-Market Alerts!

Get Pre-Market Analysts' Upgrades, Downgrades, Earnings & Initiations with our FREE daily email newsletter.